HOOKIPA Pharma Inc
NASDAQ:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
NASDAQ:HOOK
Watchlist
Price: 0.816 USD -3.77%
Market Cap: 10m USD

EV/EBITDA
Enterprise Value to EBITDA

0.4
Current
-0.1
Median
5.5
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
0.4
=
Enterprise Value
-30.4m USD
/
EBITDA
-72.4m USD
EBITDA Growth EV/EBITDA to Growth
US
HOOKIPA Pharma Inc
NASDAQ:HOOK
Average EV/EBITDA: 13.5
0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 782 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.7
10%
1.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.8
6%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.1 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.3
17%
1.2
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.3
9%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -470.5 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.8 N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
0.3
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A